Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FSTX

F-star Therapeutics (FSTX) Stock Price, News & Analysis

F-star Therapeutics logo

About F-star Therapeutics Stock (NASDAQ:FSTX)

Advanced Chart

Key Stats

Today's Range
$7.12
$7.12
50-Day Range
$4.42
$7.12
52-Week Range
$2.07
$7.12
Volume
N/A
Average Volume
709,213 shs
Market Capitalization
$156.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FSTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for F-star Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FSTX Stock News Headlines

Astria Therapeutics price target raised to $28 from $26 at Oppenheimer
Lake Street Remains a Buy on Aquestive Therapeutics (AQST)
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Bicara Therapeutics Rises 39% in Debut on Nasdaq
See More Headlines

FSTX Stock Analysis - Frequently Asked Questions

F-star Therapeutics, Inc. (NASDAQ:FSTX) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.52) earnings per share for the quarter, topping the consensus estimate of ($0.58) by $0.06. The company had revenue of $0.75 million for the quarter, compared to analyst estimates of $7.18 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that F-star Therapeutics investors own include New Age Brands (NF), Aurora Cannabis (ACB), Trican Well Service (TCW), Meta Platforms (META), NIO (NIO), Plug Power (PLUG) and Copper Mountain Mining (CMMC).

Company Calendar

Last Earnings
11/10/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FSTX
CIK
1566373
Employees
84
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.82)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.28 million
Net Margins
N/A
Pretax Margin
-213.97%
Return on Equity
-57.08%
Return on Assets
-42.40%

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
3.38
Quick Ratio
3.38

Sales & Book Value

Annual Sales
$21.17 million
Price / Sales
7.39
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.70 per share
Price / Book
1.51

Miscellaneous

Outstanding Shares
21,980,000
Free Float
21,279,000
Market Cap
$156.50 million
Optionable
Not Optionable
Beta
0.85
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:FSTX) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners